BRIEF published on 01/19/2026 at 07:35, 25 days 9 hours ago Advicenne : Demande de mise sur le marché de Sibnayal® acceptée par la FDA FDA Advicenne ATRd Sibnayal® PDUFA
BRIEF published on 01/19/2026 at 07:35, 25 days 9 hours ago La FDA examine le Sibnayal® d'Advicenne en vue de son approbation aux États-Unis. FDA Advicenne Sibnayal® DRTA Date PDUFA
BRIEF published on 01/19/2026 at 07:35, 25 days 9 hours ago FDA Reviews Advicenne's Sibnayal® for U.S. Approval FDA Advicenne Sibnayal® DRTA PDUFA Date
BRIEF published on 01/19/2026 at 07:35, 25 days 9 hours ago Advicenne: FDA-approved marketing application for Sibnayal® FDA ATRd Advicenna Sibnayal® PDUFA
PRESS RELEASE published on 01/19/2026 at 07:30, 25 days 9 hours ago Inside Information / Other news releases FDA accepts Advicenne's Marketing Authorization Application for Sibnayal® for dRTA treatment in the US, with a PDUFA decision target date of September 3rd, 2026 FDA Advicenne Sibnayal DRTA PDUFA
PRESS RELEASE published on 01/19/2026 at 07:30, 25 days 9 hours ago Informations privilégiées / Autres communiqués Advicenne annonce l'acceptation de Sibnayal pour examen par la FDA aux Etats-Unis pour le traitement de l’ATRd. Date PDUFA fixée au 3 septembre 2026 FDA Advicenne ATRd Sibnayal PDUFA
BRIEF published on 01/12/2026 at 07:35, 1 month 1 day ago Renouvellement de l'AMM de Sibnayal® dans l'Union Européenne Advicenne Maladies Rénales EMA AMM Sibnayal®
BRIEF published on 01/12/2026 at 07:35, 1 month 1 day ago Renewal of the marketing authorization for Sibnayal® in the European Union Kidney Disease EMA Advicenna AMM Sibnayal®
PRESS RELEASE published on 01/12/2026 at 07:30, 1 month 1 day ago Informations privilégiées / Autres communiqués Advicenne annonce le succès du renouvellement de l’AMM de Sibnayal® dans l’Union Européenne. L'EMA a validé l'autorisation de mise sur le marché, renforçant le développement commercial de Sibnayal® Renouvellement Union Européenne Advicenne AMM Sibnayal
BRIEF published on 11/04/2025 at 11:35, 3 months 9 days ago Advicenne submits Sibnayal® to the US FDA FDA Advicenna Sibnayal® Renal Tubular Acidosis Registration Filing
Published on 02/13/2026 at 14:35, 2 hours 14 minutes ago Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Published on 02/13/2026 at 14:30, 2 hours 19 minutes ago Golden Harp Resources Inc. Receives TSXV Final Acceptance and Closes Acquisition to Create District-Scale Copper Hill Land Package
Published on 02/13/2026 at 14:00, 2 hours 49 minutes ago Troubadour Resources Reports Assay Results from Drill Program at Senneville Gold-Silver-Copper Property
Published on 02/13/2026 at 13:37, 3 hours 12 minutes ago Atlas Salt Expands Strategic MOU with Sandvik Mining Supporting $132 Million of Equipment and Services at Great Atlantic Salt Project
Published on 02/13/2026 at 13:15, 3 hours 34 minutes ago Avino Announces Filing of Final Base Shelf Prospectus
Published on 02/13/2026 at 16:30, 19 minutes ago Open source of the Congzi AI algorithm: Transforming ordinary artificial intelligence into physical experts
Published on 02/13/2026 at 16:30, 19 minutes ago Open source de l'algorithme Congzi AI : transformer une intelligence artificielle généraliste en expert opérationnel de terrain
Published on 02/13/2026 at 15:45, 1 hour 4 minutes ago DORSIA DEBUTS THE CULTURE CALENDAR DURING ART WEEK IN MEXICO CITY AT SOL A SOL
Published on 02/13/2026 at 07:00, 9 hours 49 minutes ago Safran reports excellent financial performance in 2025 and raises its 2028 ambitions
Published on 02/13/2026 at 07:00, 9 hours 49 minutes ago Safran annonce une excellente performance financière en 2025 et relève ses ambitions pour 2028
Published on 02/12/2026 at 21:30, 19 hours 18 minutes ago Aéroports de Paris SA - 2026 Airport charges in Paris
Published on 02/12/2026 at 21:30, 19 hours 18 minutes ago Aéroports de Paris SA - Processus d'homologation tarifaire 2026
